PMID: 11337182May 5, 2001Paper

Trichosporon species infection in bone marrow transplanted patients

Diagnostic Microbiology and Infectious Disease
M L Moretti-BranchiniM Miyaji

Abstract

Trichosporon species are emerging as opportunistic agents that cause systemic diseases in immunocompromised patients. Patients undergoing bone marrow transplant are submitted to intense and prolonged periods of neutropenia and consequently to several risk factors to fungal infections as the use of broad spectrum antibiotics and invasive devices. Two cases of fungal infections caused by Trichosporon asahii var. asahii and T. inkin in patients with bone marrow transplant are described T. asahii var. asahii was responsible for fungemia and the identification of this microorganism was later performed. T. inkin caused vascular accesses infection and was recovered from an implanted Hickman-Broviac catheter. Both patients were under oral fluconazole prophylaxis. The patient with systemic infection died despite the therapy with amphotericin B and the patient with catheter-related infection recovered from the fungal infection after catheter removal. Difficulties in the identification of this microorganism lead to delays in treatment and post-mortem diagnosis.

References

May 1, 1992·Antonie van Leeuwenhoek·E GuéhoW H Batenburg-van der Vegte
Aug 1, 1989·The Journal of Infectious Diseases·H L Leaf, M S Simberkoff
Aug 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G ChaumentinD Peyramond
May 1, 1996·Mycoses·T ItohY Asada
May 9, 1998·Journal of Clinical Microbiology·T SugitaT Shinoda
Feb 2, 1999·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·V KrcmeryJ Trupl
Apr 16, 1999·The Journal of Hospital Infection·V KrcmeryD W Denning

❮ Previous
Next ❯

Citations

Dec 6, 2012·Journal of Pediatric Hematology/oncology·Vikas DuaAnupam Sachdeva
May 26, 2006·Antimicrobial Agents and Chemotherapy·Carolina SerenaJosep Guarro
Sep 29, 2006·Antimicrobial Agents and Chemotherapy·Giovanni Di BonaventuraRaffaele Piccolomini
Mar 19, 2002·Antimicrobial Agents and Chemotherapy·Niki I PaphitouJohn H Rex
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Carolina SerenaJosep Guarro
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Juan L Rodriguez-TudelaManuel Cuenca-Estrella
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Carolina SerenaJosep Guarro
Oct 7, 2011·Clinical Microbiology Reviews·Arnaldo L ColomboGuilherme M Chaves
Jul 11, 2006·Journal of Clinical Microbiology·Frances DaviesJohn L Klein
Aug 7, 2009·Journal of Clinical Microbiology·Patrick W HickeyThomas J Walsh
Dec 10, 2003·Journal of Clinical Microbiology·Miguel G MadariagaLaurie Proia
May 8, 2004·Journal of Clinical Microbiology·Jose M RamosJuan L Rodriguez-Tudela
Nov 21, 2013·The Journal of Antimicrobial Chemotherapy·Rogelio de J Treviño-RangelGloria M González
Jan 1, 2012·Medical Mycology Case Reports·Ali Akbar FallahiSassan Rezaie
Apr 5, 2011·Enfermedades infecciosas y microbiología clínica·José María AguadoUNKNOWN Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED)
Nov 14, 2015·Open Forum Infectious Diseases·Yong LiaoRongya Yang
Nov 6, 2008·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A Lacasse, K O Cleveland
Mar 9, 2007·International Journal of Dermatology·Hyun Jeong SongKyu Suk Lee
Dec 4, 2004·The Journal of Allergy and Clinical Immunology·Sarah M WynneSteven M Holland
Mar 6, 2010·International Journal of Antimicrobial Agents·Houmin LiJianzhong Zhang
Jun 25, 2014·Diagnostic Microbiology and Infectious Disease·Dulce Sachiko Yamamoto de FigueiredoGilda Maria Barbaro Del Negro
Jan 30, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T J WalshE Anaissie
Nov 2, 2016·Frontiers in Microbiology·João N de Almeida Júnior, Christophe Hennequin
May 19, 2007·Diagnostic Microbiology and Infectious Disease·Juan L Rodriguez-TudelaManuel Cuenca-Estrella
Nov 20, 2012·Mycopathologia·Gabriel Baracy KlafkeLuciano da Silva Pinto
Sep 20, 2018·BMC Infectious Diseases·Eveline Pipolo MilanGuilherme Maranhão Chaves
Jul 6, 2005·Revista de saúde pública·José Nelson Martins-DinizMaria José Soares Mendes-Giannini
Jun 24, 2008·Mycopathologia·Thomas C Chagas-NetoArnaldo L Colombo
Sep 24, 2010·Mycopathologia·Danielle Patrícia Cerqueira MacêdoRejane Pereira Neves
Apr 12, 2021·Revista iberoamericana de micología·Erick Martínez-HerreraMaría Guadalupe Frías-De-León
Jun 29, 2002·Diagnostic Microbiology and Infectious Disease·Semra KustimurTakashi Sugita
Dec 29, 2020·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Shin-Huei KuoShang-Yi Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Burns : Journal of the International Society for Burn Injuries
M J CawleyM L Patton
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J R EbrightJ A Vazquez
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Daniel GoodmanKent Sepkowitz
The Pediatric Infectious Disease Journal
J A PiwozC Cummingham-Rundles
© 2021 Meta ULC. All rights reserved